BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 21451121)

  • 1. The precompetitive space: time to move the yardsticks.
    Norman T; Edwards A; Bountra C; Friend S
    Sci Transl Med; 2011 Mar; 3(76):76cm10. PubMed ID: 21451121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leveraging crowdsourcing to facilitate the discovery of new medicines.
    Norman TC; Bountra C; Edwards AM; Yamamoto KR; Friend SH
    Sci Transl Med; 2011 Jun; 3(88):88mr1. PubMed ID: 21697527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The Innovative Medicine Initiative (IMI)].
    Bril A; Canet E
    Med Sci (Paris); 2008 Oct; 24(10):885-90. PubMed ID: 18950588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Public-private partnerships to revitalize psychiatric drug discovery.
    Brady LS; Potter WZ
    Expert Opin Drug Discov; 2014 Jan; 9(1):1-8. PubMed ID: 24308355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mandela calls for greater commitment and leadership in fighting AIDS. The World Economic Forum -- Policy and business in a world of HIV / AIDS.
    Macinnis R
    AIDSlink; 1997; (43):1, 3. PubMed ID: 12321752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drugs for Neglected Diseases initiative model of drug development for neglected diseases: current status and future challenges.
    Ioset JR; Chang S
    Future Med Chem; 2011 Sep; 3(11):1361-71. PubMed ID: 21879842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to create a public-private partnership: a replicable project associated with business continuity.
    Hahn D
    J Bus Contin Emer Plan; 2010 Jul; 4(3):274-85. PubMed ID: 20826390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Open-access public-private partnerships to enable drug discovery--new approaches.
    Müller S; Weigelt J
    IDrugs; 2010 Mar; 13(3):175-80. PubMed ID: 20191434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicines discovery in the 21st century: the case for a stakeholder corporation.
    Dixon J; England P; Lawton G; Machin P; Palmer A
    Drug Discov Today; 2010 Sep; 15(17-18):700-3. PubMed ID: 20678583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementing and using quality measures for children's health care: perspectives on the state of the practice.
    Shaller D
    Pediatrics; 2004 Jan; 113(1 Pt 2):217-27. PubMed ID: 14702504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Clinical Trials Transformation Initiative (CTTI).
    Grignolo A
    Ann Ist Super Sanita; 2011; 47(1):14-8. PubMed ID: 21430332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug discovery dilemma and Cura quartet collaboration.
    Shah S; Federoff HJ
    Drug Discov Today; 2009 Nov; 14(21-22):1006-10. PubMed ID: 19815089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing private sector engagement: Louisiana's business emergency operations centre.
    Day JM; Strother S; Kolluru R; Booth J; Rawls J; Calderon A
    J Bus Contin Emer Plan; 2010 Jul; 4(3):216-30. PubMed ID: 20826386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brazil: An emerging partner in drug R&D.
    Rodrigues DG
    IDrugs; 2009 Aug; 12(8):497-502. PubMed ID: 19629884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Public-private partnership: from there to here.
    Croft SL
    Trans R Soc Trop Med Hyg; 2005 Oct; 99 Suppl 1():S9-14. PubMed ID: 16087204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community health outreach program of the Chad-Cameroon petroleum development and pipeline project.
    Utzinger J; Wyss K; Moto DD; Tanner M; Singer BH
    Clin Occup Environ Med; 2004 Feb; 4(1):9-26. PubMed ID: 15043361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [French biomedical competitiveness clusters: opportunities for public-private partnerships].
    Vasmant D
    Bull Acad Natl Med; 2009 Dec; 193(9):2035-43; discussion 2044. PubMed ID: 20666016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is pharma running out of brainy ideas?
    Miller G
    Science; 2010 Jul; 329(5991):502-4. PubMed ID: 20671165
    [No Abstract]   [Full Text] [Related]  

  • 19. Sharing the burden of TB/HIV? Costs and financing of public-private partnerships for tuberculosis treatment in South Africa.
    Sinanovic E; Kumaranayake L
    Trop Med Int Health; 2006 Sep; 11(9):1466-74. PubMed ID: 16930269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Four disruptive strategies for removing drug discovery bottlenecks.
    Ekins S; Waller CL; Bradley MP; Clark AM; Williams AJ
    Drug Discov Today; 2013 Mar; 18(5-6):265-71. PubMed ID: 23098820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.